Clinical Trials
440 trialsMultiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Thomas Jefferson University
Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
VA Office of Research and Development
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
ENDEAVOR
University of Florence
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Antelope Surgical Solutions, Inc
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?
Tianjin Medical University Second Hospital
Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic Prostaectomy
Cairo University
ALTER-UC-011
Tianjin Medical University Cancer Institute and Hospital
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
Huahui Health
ZENITH
Hoosier Cancer Research Network
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
GV20 Therapeutics
Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer
Harbin Medical University
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Blue Earth Diagnostics
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Exelixis
PROCAN-B+
University of Sunderland
Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
Norroy Bioscience Co., LTD
ENGAGE
Georgetown University
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Regeneron Pharmaceuticals
HYPNO-AJA2
Institut Bergonié
Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy
University of Kentucky
HOPE-07-MIBC
West China Hospital
Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer
Case Comprehensive Cancer Center
DOTA-STR-17126
Integrated Haematology and Oncology Network
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
University of Wisconsin, Madison
A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
The Effect of Pelvic Floor Muscle Exercises After Radical Prostatectomy
KTO Karatay University
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
Roswell Park Cancer Institute
Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer
Yonsei University
Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma
RenJi Hospital
Moonlanding
Vall d'Hebron Institute of Oncology
iCCaRE
University of Ilorin Teaching Hospital
SWAP
Philogen S.p.A.
AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
University of Arkansas
MILA
Koelis
High-resolution Intra-operative PSMA PET-CT in Prostate Cancer
IRCCS San Raffaele
Lutécio
Instituto do Cancer do Estado de São Paulo
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
M.D. Anderson Cancer Center
MOMENT
Prostate Cancer Clinical Trials Consortium
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
Washington University School of Medicine
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Regeneron Pharmaceuticals
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
National Cancer Institute (NCI)
DARE
Bayer
dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy
Mochida Medical USA, Inc.
PROSPECTOR
AstraZeneca
HARP
University of Zurich
CaBRA
Gustave Roussy, Cancer Campus, Grand Paris
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
University of Washington